To date, cathepsin Z has been found to be involved in cancer models (22, 39, 40), rheumatoid arthritis (41), Alzheimer’s disease (42), Sjogren’s syndrome (43), and primary biliary cholangitis (44). Here, CTSZ is linked to cancer.